Stimulant Use Disorders

3

Review clinical trials related to Stimulant Use Disorders. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Culturally Adapted Contingency Management

The purpose of this study is to develop a culturally adapted contingency management (CM) protocol for Black adults with stimulant use disorder.

Participants needed: 70
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Yale UniversityUpdated: Jul 1, 2026Locations: 1
Eligibility criteria

participants must self-identify as Black/African American [+1]

individuals who are intoxicated or otherwise unable to provide consent

Status: Recruiting

Kentucky Women's Justice Community Overdose Innovation Network - Phase II

This project continues our work with women in the Kentucky Women's Justice Community Overdose Innovation Network Phase II (WJCOIN-II) with the overall aim of reducing overdose risk during the transition from jail to rural communities. WJCOIN-II has potential for significant impact regarding the effectiveness, implementation, and sustainability of innovative overdose prevention strategies during the high-risk time of community re-entry among vulnerable, CLS-involved women in rural communities. This research will impact the field by increasing the capacity of the criminal legal system to respond to the overdose crisis through increased access to prevention strategies to reduce overdose risk.

Participants needed: 300
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Michele StatonUpdated: Jul 1, 2026Locations: 1
Eligibility criteria

DSM-5 scores of 2+ for opioids (OUD) and/or stimulants (StUD), [+4]

Not living in a rural area [+1]

Status: Not yet recruiting

Optimizing Pregnancy and Treatment Interventions for Moms 3.0

We want to learn if Patient Navigation helps pregnant Medicaid members with opioid use disorder, with or without stimulant use disorder, stay in care, use medications for opioid use disorder, reduce substance use, and connect with services, compared to usual care. Enrolled participants will be randomly assigned (by chance, like flipping a coin) to one of two groups: Usual Care or Patient Navigation. Participate will last up to 14 months and participants randomized to Patient Navigation may have about 14 sessions/calls with a Patient Navigator (30-45 minutes each) and complete 3 surveys (30-60 minutes each). All visits can be by phone or video.

Participants needed: 429
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: University of UtahUpdated: May 15, 2026Locations: 1
Eligibility criteria

Adult (≥18 years) [+5]

Plan to terminate pregnancy [+5]